Treatment of generalized anxiety disorders

被引:2
作者
Etchegaray, Mayena [1 ]
Hardy, Patrick [1 ]
机构
[1] Univ Paris 11, CHU Bicetre, Psychiat Serv, AP HP,INSERM,U669, F-94275 Le Kremlin Bicetre, France
来源
PRESSE MEDICALE | 2008年 / 37卷 / 05期
关键词
D O I
10.1016/j.lpm.2008.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Generalized anxiety disorder (GAD) is a condition that is comman in the general population and in general practice,. it is disabling and often unrecognized. Its recognition is difficult because of the need to differentiate between normal anxiety and the other psychiatric disorders with which it is often associated. The primary drugs used for GAD are the antidepressants that have been authorized for this indication (venlafaxine XR, paroxetine, and escitalopram). Although benzodiazepines are effective, their prescription is limited by the disadvantages associated with their long-term use. Drug treatment of GAD must continue for a sufficiently long period (at least 6 months) to minimize the chance of a relapse. Cognitive and behavioral therapies (CBT) are as effective as antidepressants. They ore often desirable, but their limited availability impedes their use as a first-line treatment.
引用
收藏
页码:859 / 866
页数:8
相关论文
共 29 条
  • [1] *AG NAT ACCR EV SA, 2001, DIAGN PRIS CHARG AMB
  • [2] Efficacy of sertraline in a 12-week trial for generalized anxiety disorder
    Allgulander, C
    Dahl, AA
    Austin, C
    Morris, PLP
    Sogaard, JA
    Fayyad, R
    Kutcher, SP
    Clary, CM
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (09) : 1642 - 1649
  • [3] ALLGULANDER C, 2005, INT J NEUROPSYCHOPH, V9, P1
  • [4] [Anonymous], 2003, DSM 4 T MAN DIAGN ST
  • [5] Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
    Baldwin, DS
    Anderson, IM
    Nutt, DJ
    Bandelow, B
    Bond, A
    Davidson, JRT
    den Boer, JA
    Fineberg, NA
    Knapp, M
    Scott, J
    Wittchen, HU
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (06) : 567 - 596
  • [6] Current treatments of the anxiety disorders in adults
    Ballenger, JC
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 46 (11) : 1579 - 1594
  • [7] Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53
  • [8] Bandelow Borwin, 2007, Expert Rev Neurother, V7, P769, DOI 10.1586/14737175.7.7.769
  • [9] Bielski Robert J, 2005, Ann Clin Psychiatry, V17, P65, DOI 10.1080/10401230590932326
  • [10] Boulenger JP, 2007, ENCEPHALE, V33, P84